Cargando…
Surveillance of hepatocellular carcinoma in cirrhotic patients: Current knowledge and future directions
Patients with cirrhosis are at the highest risk to develop hepatocellular carcinoma (HCC), with a variable annual risk of 1–8%. Currently, biannual abdominal ultrasound (USG) with or without alpha fetoprotein (AFP) is the recommended HCC surveillance strategy of major professional liver societies fo...
Autores principales: | Demirtas, Coskun Ozer, Ozdogan, Osman Cavit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349494/ https://www.ncbi.nlm.nih.gov/pubmed/35949723 http://dx.doi.org/10.14744/hf.2020.2020.0003 |
Ejemplares similares
-
Palliative care in cirrhotic patients: Brief summary of recent AASLD guidance
por: Ozdogan, Osman Cavit
Publicado: (2022) -
Evaluation of the effectiveness of drug-eluting transarterial chemoebolization in hepatocellular carcinoma
por: Alan, Aydan Mutis, et al.
Publicado: (2023) -
Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
por: Demirtas, Coskun Ozer, et al.
Publicado: (2021) -
Practicality and potential restrictions of unresectable hepatocellular carcinoma prognostic index
por: Demirtas, Coskun Ozer, et al.
Publicado: (2022) -
Proposal and Validation of a Novel Scoring System for Hepatocellular Carcinomas Beyond Curability Borders
por: Demirtas, Coskun Ozer, et al.
Publicado: (2021)